Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use

[1] Maurya SK(2022)Insights on epidemiology, pathogenesis, diagnosis and possible treatment of COVID-19 infection Proc Natl Acad Sci India Sect B Biol Sci 8 61-69

[2] Bhattacharya A(2011)Drug repurposing from an academic perspective Drug Discov Today Ther Strateg 18 41-58

[3] Shukla P(2019)Drug repurposing: progress, challenges and recommendations Nat Rev Drug Discov 11 1-793

[4] Oprea TI(2020)Challenges for drug repurposing in the COVID-19 pandemic era Front Pharmacol 4 324-422

[5] Bauman JE(2015)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Syst Rev 25 420-2629

[6] Bologa CG(2020)Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review J Am Med Assoc 8 2620-768

[7] Pushpakom S(2020)Pathological findings of COVID-19 associated with acute respiratory distress syndrome Lancet Respir Med 130 762-422

[8] Iorio F(2020)Clinical and immunological features of severe and moderate coronavirus disease J Clin Invest 71 11-1034

[9] Eyers PA(2020)Dysregulation of immune response in patients with COVID-19 in Wuhan, China Clin Infect Dis 7 415-75

[10] Sultana J(2020)The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status Mil Med Res 34 1033-499

[1] Maurya SK(2022)Insights on epidemiology, pathogenesis, diagnosis and possible treatment of COVID-19 infection Proc Natl Acad Sci India Sect B Biol Sci 8 61-69

[2] Bhattacharya A(2011)Drug repurposing from an academic perspective Drug Discov Today Ther Strateg 18 41-58

[3] Shukla P(2019)Drug repurposing: progress, challenges and recommendations Nat Rev Drug Discov 11 1-793

[4] Oprea TI(2020)Challenges for drug repurposing in the COVID-19 pandemic era Front Pharmacol 4 324-422

[5] Bauman JE(2015)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Syst Rev 25 420-2629

[6] Bologa CG(2020)Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review J Am Med Assoc 8 2620-768

[7] Pushpakom S(2020)Pathological findings of COVID-19 associated with acute respiratory distress syndrome Lancet Respir Med 130 762-422

[8] Iorio F(2020)Clinical and immunological features of severe and moderate coronavirus disease J Clin Invest 71 11-1034

[9] Eyers PA(2020)Dysregulation of immune response in patients with COVID-19 in Wuhan, China Clin Infect Dis 7 415-75

[10] Sultana J(2020)The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status Mil Med Res 34 1033-499